A detailed history of Hillsdale Investment Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 1,394 shares of BMY stock, worth $56,387. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,394
Previous 2,224 37.32%
Holding current value
$56,387
Previous $114,000 34.21%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $39,823 - $45,152
-830 Reduced 37.32%
1,394 $75,000
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $383,810 - $429,159
-6,630 Reduced 74.88%
2,224 $129,000
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $6,570 - $7,453
-100 Reduced 1.12%
8,854 $613,000
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $69,849 - $82,711
-1,020 Reduced 10.23%
8,954 $644,000
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $25 - $15,060
196 Added 2.0%
9,974 $709,000
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $29,048 - $31,992
-400 Reduced 3.93%
9,778 $753,000
Q1 2022

Apr 28, 2022

BUY
$61.48 - $73.72 $12,296 - $14,744
200 Added 2.0%
10,178 $744,000
Q3 2021

Oct 21, 2021

BUY
$59.17 - $69.31 $532,530 - $623,790
9,000 Added 920.25%
9,978 $590,000
Q2 2021

Jul 29, 2021

SELL
$61.91 - $67.42 $50,270 - $54,745
-812 Reduced 45.36%
978 $65,000
Q1 2021

Apr 22, 2021

BUY
$59.34 - $66.74 $7,714 - $8,676
130 Added 7.83%
1,790 $113,000
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $432,472 - $490,070
-7,490 Reduced 81.86%
1,660 $103,000
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $18,377 - $20,364
-320 Reduced 3.38%
9,150 $552,000
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $5,482 - $6,409
-100 Reduced 1.04%
9,470 $557,000
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $379,088 - $550,903
8,170 Added 583.57%
9,570 $533,000
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $28,228 - $33,468
-660 Reduced 32.04%
1,400 $71,000
Q2 2019

Aug 02, 2019

SELL
$44.62 - $49.34 $394,887 - $436,659
-8,850 Reduced 81.12%
2,060 $93,000
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $153,859 - $183,458
3,410 Added 45.47%
10,910 $521,000
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $378,975 - $472,350
7,500 New
7,500 $415,000
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $349,932 - $402,843
-5,840 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
5,840
5,840 $326,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.